<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101652055</journal-id>
<journal-id journal-id-type="pubmed-jr-id">43566</journal-id>
<journal-id journal-id-type="nlm-ta">J Nat Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">J Nat Sci</journal-id>
<journal-title-group>
<journal-title>Journal of nature and science</journal-title>
</journal-title-group>
<issn pub-type="epub">2377-2700</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28959732</article-id>
<article-id pub-id-type="pmc">5613287</article-id>
<article-id pub-id-type="manuscript">NIHMS906707</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down’s syndrome (DS; trisomy 21)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yuhai</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaber</surname>
<given-names>Vivian</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Percy</surname>
<given-names>Maire E.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lukiw</surname>
<given-names>Walter J.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Anatomy and Cell Biology, Louisiana State University Health Science Center, New Orleans, LA 70112, USA</aff>
<aff id="A2">
<label>2</label>LSU Neuroscience Center, Louisiana State University Health Science Center, New Orleans, LA 70112, USA</aff>
<aff id="A3">
<label>3</label>Department of Physiology, University of Toronto, Toronto, Canada</aff>
<aff id="A4">
<label>4</label>Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada</aff>
<aff id="A5">
<label>5</label>Surrey Place Centre, Toronto, Canada</aff>
<aff id="A6">
<label>6</label>Department of Ophthalmology, Louisiana State University Health Science Center, New Orleans, LA 70112, USA</aff>
<aff id="A7">
<label>7</label>Department of Neurology, Louisiana State University Health Science Center, New Orleans, LA 70112, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Walter J. Lukiw, BS, MS, PhD. LSU Neuroscience Center, Louisiana State University Health Sciences Center, 2020 Gravier Street, Suite 904, New Orleans, LA 70112-2272, USA. <email>wlukiw@lsuhsc.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>Conflict of Interest: No conflicts declared.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>19</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>3</volume>
<issue>9</issue>
<elocation-id>e446</elocation-id>
<self-uri xlink:href="http://www.jnsci.org/files/html/2017/e446.htm"></self-uri>
<abstract>
<p id="P1">Down’s syndrome (DS) is the most common genetic cause of intellectual disability and cognitive deficit attributable to a naturally-occurring abnormality of gene dosage. DS is caused by a triplication of all or part of human chromosome 21 (chr21) and currently there are no effective treatments for this incapacitating disorder of neurodevelopment. First described by the English physician John Langdon Down in 1862, propelled by the invention of karyotype analytical techniques in the early 1950s and the discovery in 1959 by the French geneticist Jerome Lejune that DS resulted from an extra copy of chr21, DS was the first neurological disorder linking a chromosome dosage imbalance to a defect in intellectual development with ensuing cognitive disruption. Especially over the last 60 years, it has been repeatedly demonstrated that DS is not an easily defined disease entity but rather possesses a remarkably <italic>wide variability</italic> in the ‘<italic>phenotypic spectrum</italic>’ associated with this trisomic disorder. This commentary describes the presence of a 5 member cluster of chr21-encoded microRNAs (miRNAs) that includes let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802 located on the long arm of human chr21, spanning the chr21q21.1-chr21q21.3 region and flanking the beta amyloid precursor (βAPP) gene, and reviews the potential contribution of these 5 miRNAs to the remarkably diverse DS phenotype.</p>
</abstract>
<kwd-group>
<kwd>42 amino acid amyloid-beta (Aβ42) peptide</kwd>
<kwd>Alzheimer’s disease (AD)</kwd>
<kwd>beta amyloid precursor protein (βAPP)</kwd>
<kwd>Down’s Syndrome</kwd>
<kwd>microRNA (miRNA)</kwd>
<kwd>small non-coding RNAs (sncRNAs)</kwd>
<kwd>systemic inflammation</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>